23/10/2024 New Alzheimer's drug rejected for widespread use in NHS in England
The health spending watchdog said it was too expensive for too little benefit
The health spending watchdog said it was too expensive for too little benefit
The health spending watchdog said it was too expensive for too little benefit
The health spending watchdog said it was too expensive for too little benefit